Eric Sherb named CFO at Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US appointed Eric Sherb as Chief Financial Officer, effective October 1, 2026. He replaces Erick Frim, who resigned as Interim Chief Financial Officer effective September 29, 2026.